This site is intended for U.S. healthcare professionals.

Visit Pfizer Medical

Menu

Close

Sign InLog Out
ProductsOrderMaterialsCo-pay Cards & Patient Savings OffersRequest SamplesHospital ProductsVaccinesPatient AssistancePfizer Oncology TogetherPfizer RxPathwaysExplore ContentEventsMaterialsVideosContact
Search

Menu

Close

AboutAboutEfficacyMOAMist MomentsSafety & DosingSafety &
Dosing
SafetyDosing
PrescribingPrescribingAccess & SavingsZavzpret OneSourcePractice ResourcesPractice ResourcesEventsMaterialsVideosPA Resources
Prescribing InformationPatient Information Instructions for UseIndication Press Release
Do your patients with migraine miss out on moments?Do your patients with migraine miss out on moments?

When a migraine attack strikes during the school day, Ben uses ZAVZPRETTM (zavegepant) to get him back to class quickly.

Ben’s Mist moments
  • Frequently experiences migraine attacks during school days
  • Finds himself with a migraine attack while teaching and endures pain
  • Looking for a treatment option that helps him get relief from migraine pain quickly
Ben’s Mist moments
  • Frequently experiences migraine attacks during school days
  • Finds himself with a migraine attack while teaching and endures pain
  • Looking for a treatment option that helps him get relief from migraine pain quickly
“My students rely on me, and I don’t have much of a choice other than to keep teaching. I need an option that helps me get back to work quickly when a migraine attack strikes during the school day.”

Zoe uses ZAVZPRET to quickly get her back to her kids.

Zoe’s Mist moments
  • Experiences diverse migraine attacks, often coming on fast in the mornings
  • Her migraine attacks often disrupt her morning routine when she is needed the most
  • Determined to find an option that helps her get back to her responsibilities quickly
Zoe’s Mist moments
  • Experiences diverse migraine attacks, often coming on fast in the mornings
  • Her migraine attacks often disrupt her morning routine when she is needed the most
  • Determined to find an option that helps her get back to her responsibilities quickly
“When migraine comes crashing in with no warning, I still need to tend to my kids and get to work.”
If you see patients like Ben or Zoe in your practice, consider adding ZAVZPRET to their migraine toolbox. Learn more about getting started with ZAVZPRET here.
Access support Loading
Connect with a sales representative to learn more
Request a representative Loading
Explore the phase 3 pivotal trial results See efficacy Loading Resources

Download helpful resources for you and your practice

Explore resources Loading
References:Zavzpret. Package insert. Pfizer Inc.

To report an adverse event, please call 1-800-438-1985

Pfizer for Professionals 1-800-505-4426

This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

© 2024 Pfizer Inc. All rights reserved.

PP-ZAZ-USA-0093
You are now leaving Pfizer You are now leaving a Pfizer operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.
PP-MCL-USA-0367


​​​​​​​
INDICATION

ZAVZPRETTM (zavegepant) is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use: ZAVZPRET is not indicated for the preventive treatment of migraine.

Important Safety Information Contraindications: Hypersensitivity to ZAVZPRET or any of its components.

Warnings and Precautions: Hypersensitivity reactions, including facial swelling and urticaria, have occurred with ZAVZPRET. If a hypersensitivity reaction occurs, discontinue ZAVZPRET and initiate appropriate therapy.

Adverse Reactions: Most common adverse reactions (occurring in ≥2% of patients treated with ZAVZPRET and greater than placebo) for ZAVZPRET vs placebo were taste disorders including dysgeusia and ageusia (18% vs 4%), nausea (4% vs 1%), nasal discomfort (3% vs 1%), and vomiting (2% vs 1%).

Drug Interactions: Avoid use with drugs that inhibit or induce OATP1B3 or NTCP transporters. Avoid use of intranasal decongestants; if unavoidable, administer intranasal decongestants at least 1 hour after ZAVZPRET administration.

Use in Specific Populations: Hepatic Impairment: Avoid use in patients with severe hepatic impairment. Renal impairment: Avoid use of ZAVZPRET in patients with creatinine clearance (CLcr) less than 30 mL/min.

Please click here for full Prescribing Information.
IndicationZAVZPRET™️ (zavegepant) is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use: ZAVZPRET is not indicated for the preventive treatment of migraine.

Please see Full Prescribing Information.